Heidelberg Pharma AG HPHA

LADENBURG, GERMANY - August 26, 2026 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that the China National Medical Products Administration...

All agenda items approved by a large majority 2026 Annual General Meeting elects Jack Yefei Ling as new member of the Supervisory Board LADENBURG, GERMANY - June 23, 2026 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biote...

LADENBURG, GERMANY - April 6, 2026 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), will present promising preclinical data from its Amanitin-based ADC HDP-...

As European markets continue to show optimism with major stock indexes rising, investors are increasingly looking towards smaller companies for potential opportunities. Penny stocks, a term that may seem outdated but still relevant, often refer to smaller or newer companies that can offer a blend of affordability and growth potential. By focusing on those with strong financials and clear growth prospects, investors might find these under-the-radar stocks appealing as they explore the...

As the European markets navigate mixed performances, with notable fluctuations in major indices like Germany’s DAX and France’s CAC 40, investors continue to assess opportunities amidst economic uncertainties. Penny stocks, though a term from past market eras, still hold potential for those seeking value in smaller or newer companies. These stocks can offer affordability and growth potential when supported by strong financials, making them intriguing options for investors looking beyond...